BioSpace News Archive

Truepill announced that it is launching a new B2B pharmacy fulfillment service which powers direct-to-consumer healthcare brands like Hims and Nurx.

Osage University Partners, a Philadelphia area-based venture capital firm, announced the closing of Osage University Partners III, L.P. at $273 million, exceeding its target of $250 million.

At an Analyst Day event held today in New York City, Ligand Pharmaceuticals Incorporated reviewed the recent progress of its business and financial growth outlook.

Amendola Communications, a nationally recognized, award-winning healthcare and healthcare technology public relations and marketing agency, announced that Louie Holwerk has joined the agency as Senior Writer.

The U.S. Food and Drug Administration published four draft guidances and one final guidance regarding cancer trial eligibility criteria.

National Federation of the Blind Comments on Forthcoming TV Series

Epizyme, Inc. announced the closing of its two concurrent underwritten public offerings of 11,500,000 shares of its common stock and 350,000 shares of its non-voting Series A Convertible Preferred Stock, which includes the full exercise by the underwriters of their separate options in each of the respective offerings to purchase additional shares at the public offering price.

BC Cancer’s Breast Screening Program have selected MagView as their choice for a Breast Imaging Electronic Software Solution.

Two distinct clinical studies demonstrate Mako Total Knee associated with less pain, less need for opiate analgesics, less need for in-patient physical therapy, reduction in length of hospital stay, improved knee flexion and soft tissue protection in comparison to manual techniques

Farmers will be able to renew their training on the safe handling and use of anhydrous ammonia fertilizer – a key nitrogen input – with Fertilizer Canada’s newly-updated educational manual and video that provide more recent and comprehensive information.